semaglutide safety concerns Updates in Medicine | 🩺 Oral Cuts CV Risk in High-Risk T2DM – SOUL Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹 An Ongoing Crisis: Semaglutide Shortage

Mild cognitive impairment often precedes Alzheimers disease

Unlike growth hormone therapies that stimulate pituitary secretion, IGF-1 LR3 directly activates cellular growth and repair pathways

Third-Party Purity Verification : We verify each batch through comprehensive third-party labs using advanced analytical methods to confirm molecular structure, purity levels, and absence of contaminants before release

Always have an amazing experience at synergy

The list prices below are not necessarily what you will pay, as the price varies by pharmacy and insurance coverage

Human trials are underway to test their use in Parkinsons and cognitive decline